Moderna (MRNA) Ratios
Moderna Ratios
MX:MRNA's free cash flow for Q2 2026 was $-563.00M. For the 2026 fiscal year, MX:MRNA's free cash flow was decreased by $-37.00M and operating cash flow was $-526.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.29 | 3.67 | 3.42 | 2.73 | 1.76 |
| Quick Ratio | 3.22 | 3.62 | 3.36 | 2.54 | 1.60 |
| Cash Ratio | 1.31 | 0.87 | 0.96 | 0.65 | 0.75 |
| Solvency Ratio | -0.71 | -1.04 | -0.90 | 1.29 | 1.18 |
| Operating Cash Flow Ratio | -0.94 | -1.36 | -1.03 | 1.01 | 1.49 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 2.86B | $ 4.86B | $ 5.75B | $ 6.70B | $ 5.55B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.16 | 0.05 | 0.07 | 0.05 | 0.04 |
| Debt-to-Equity Ratio | 0.22 | 0.07 | 0.09 | 0.06 | 0.06 |
| Debt-to-Capital Ratio | 0.18 | 0.06 | 0.08 | 0.06 | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.43 | 1.30 | 1.33 | 1.35 | 1.74 |
| Debt Service Coverage Ratio | -260.70 | -139.50 | -106.71 | 295.00 | 691.39 |
| Interest Coverage Ratio | -307.40 | -164.38 | -111.55 | 324.83 | 738.67 |
| Debt to Market Cap | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 4.95 | 2.01 | 3.35 | 3.12 | 2.32 |
| Net Debt to EBITDA | 0.27 | 0.35 | 0.51 | -0.21 | -0.44 |
| Profitability Margins | |||||
| Gross Profit Margin | 55.35% | 54.24% | 31.47% | 71.31% | 85.24% |
| EBIT Margin | -142.39% | -112.00% | -57.01% | 49.91% | 74.97% |
| EBITDA Margin | -131.33% | -106.10% | -47.94% | 51.75% | 76.27% |
| Operating Profit Margin | -158.13% | -123.32% | -61.90% | 49.91% | 74.97% |
| Pretax Profit Margin | -142.39% | -112.75% | -57.56% | 50.73% | 74.90% |
| Net Profit Margin | -145.16% | -111.32% | -68.84% | 44.30% | 68.80% |
| Continuous Operations Profit Margin | -145.16% | -111.32% | -68.84% | 44.30% | 68.80% |
| Net Income Per EBT | 101.95% | 98.72% | 119.58% | 87.33% | 91.85% |
| EBT Per EBIT | 90.05% | 91.43% | 92.99% | 101.65% | 99.92% |
| Return on Assets (ROA) | -22.87% | -25.18% | -25.58% | 32.34% | 49.46% |
| Return on Equity (ROE) | -32.62% | -32.67% | -34.03% | 43.73% | 86.26% |
| Return on Capital Employed (ROCE) | -29.70% | -33.05% | -27.51% | 45.00% | 85.55% |
| Return on Invested Capital (ROIC) | -29.70% | -32.53% | -27.46% | 38.93% | 77.53% |
| Return on Tangible Assets | -23.05% | -25.35% | -25.72% | 32.34% | 49.46% |
| Earnings Yield | -24.60% | -22.30% | -12.41% | 11.82% | 11.92% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.85 | 5.40 | 6.33 | 11.20 | 5.34 |
| Payables Turnover | 2.74 | 3.61 | 9.03 | 11.12 | 8.67 |
| Inventory Turnover | 5.67 | 12.51 | 23.23 | 5.71 | 1.82 |
| Fixed Asset Turnover | 0.68 | 1.08 | 2.58 | 8.82 | 12.82 |
| Asset Turnover | 0.16 | 0.23 | 0.37 | 0.73 | 0.72 |
| Working Capital Turnover Ratio | 0.37 | 0.48 | 0.87 | 2.44 | 4.01 |
| Cash Conversion Cycle | -15.64 | -4.26 | 32.88 | 63.72 | 227.25 |
| Days of Sales Outstanding | 53.32 | 67.55 | 57.62 | 32.58 | 68.39 |
| Days of Inventory Outstanding | 64.34 | 29.17 | 15.71 | 63.96 | 200.98 |
| Days of Payables Outstanding | 133.30 | 100.97 | 40.44 | 32.82 | 42.12 |
| Operating Cycle | 117.66 | 96.72 | 73.33 | 96.54 | 269.37 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -4.81 | -7.82 | -8.16 | 12.64 | 33.80 |
| Free Cash Flow Per Share | -5.31 | -10.56 | -10.01 | 11.63 | 33.09 |
| Dividend Paid and CapEx Coverage Ratio | -9.76 | -2.86 | -4.41 | 12.45 | 47.96 |
| Capital Expenditure Coverage Ratio | -9.76 | -2.86 | -4.41 | 12.45 | 47.96 |
| Operating Cash Flow Coverage Ratio | -0.98 | -4.02 | -2.51 | 4.15 | 14.87 |
| Operating Cash Flow to Sales Ratio | -0.96 | -0.94 | -0.46 | 0.26 | 0.77 |
| Free Cash Flow Yield | -18.00% | -25.40% | -10.07% | 6.47% | 13.03% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.06 | -4.49 | -8.06 | 8.46 | 8.39 |
| Price-to-Sales (P/S) Ratio | 5.90 | 4.99 | 5.55 | 3.75 | 5.77 |
| Price-to-Book (P/B) Ratio | 1.33 | 1.46 | 2.74 | 3.70 | 7.24 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.56 | -3.94 | -9.93 | 15.45 | 7.68 |
| Price-to-Operating Cash Flow Ratio | -6.12 | -5.32 | -12.18 | 14.21 | 7.51 |
| Price-to-Earnings Growth (PEG) Ratio | 0.19 | 0.18 | 0.05 | -0.28 | -0.01 |
| Enterprise Value Multiple | -4.23 | -4.36 | -11.06 | 7.04 | 7.13 |
| Enterprise Value | 10.79B | 14.79B | 36.33B | 68.77B | 96.42B |
| EV to EBITDA | -4.23 | -4.36 | -11.06 | 7.04 | 7.13 |
| EV to Sales | 5.55 | 4.62 | 5.30 | 3.64 | 5.44 |
| EV to Free Cash Flow | -5.23 | -3.65 | -9.50 | 15.01 | 7.23 |
| EV to Operating Cash Flow | -5.76 | -4.92 | -11.65 | 13.81 | 7.08 |
| Tangible Book Value Per Share | 21.99 | 28.15 | 36.02 | 48.54 | 35.10 |
| Shareholders’ Equity Per Share | 22.24 | 28.39 | 36.27 | 48.54 | 35.10 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.02 | 0.01 | -0.20 | 0.13 | 0.08 |
| Revenue Per Share | 5.00 | 8.33 | 17.93 | 47.91 | 44.01 |
| Net Income Per Share | -7.25 | -9.27 | -12.34 | 21.22 | 30.28 |
| Tax Burden | 1.02 | 0.99 | 1.20 | 0.87 | 0.92 |
| Interest Burden | 1.00 | 1.01 | 1.01 | 1.02 | 1.00 |
| Research & Development to Revenue | 1.61 | 1.42 | 0.71 | 0.17 | 0.11 |
| SG&A to Revenue | 0.52 | 0.37 | 0.20 | 0.05 | 0.00 |
| Stock-Based Compensation to Revenue | 0.25 | 0.13 | 0.04 | 0.01 | 0.01 |
| Income Quality | 0.66 | 0.84 | 0.66 | 0.60 | 1.12 |
Currency in USD
